Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Globus Medical, Inc. Class A Common Stock
(NY:
GMED
)
85.58
+0.81 (+0.95%)
Streaming Delayed Price
Updated: 11:15 AM EDT, Mar 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Globus Medical, Inc. Class A Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Price Over Earnings Overview: Globus Medical
↗
January 06, 2025
Via
Benzinga
Why GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock.
↗
December 31, 2024
Delving into GLOBUS MEDICAL INC - A (NYSE:GMED)'s high Growth Prospects.
Via
Chartmill
16 Analysts Have This To Say About Globus Medical
↗
December 18, 2024
Via
Benzinga
Inari Medical Stock Gets RS Rating Upgrade
↗
December 11, 2024
On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.
Via
Investor's Business Daily
Should you consider GLOBUS MEDICAL INC - A (NYSE:GMED) for high growth investing?
↗
December 10, 2024
Unlocking the high Growth Potential of GLOBUS MEDICAL INC - A (NYSE:GMED).
Via
Chartmill
Novocure Stock Earns 96 RS Rating
↗
December 03, 2024
On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73.
Via
Investor's Business Daily
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
↗
December 02, 2024
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via
Benzinga
Evaluating Globus Medical: Insights From 11 Financial Analysts
↗
December 02, 2024
Via
Benzinga
What 7 Analyst Ratings Have To Say About Globus Medical
↗
November 06, 2024
Via
Benzinga
Globus Medical Launches ExcelsiusHub™ Navigation System
November 22, 2024
From
Globus Medical
Via
GlobeNewswire
Despite its growth, NYSE:GMED remains within the realm of affordability.
↗
November 07, 2024
GLOBUS MEDICAL INC - A (NYSE:GMED) stands out as a growth opportunity that won't break the bank.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 06, 2024
Via
Benzinga
CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday
↗
November 06, 2024
Via
Benzinga
Globus Medical (GMED) Q3 2024 Earnings Call Transcript
↗
November 05, 2024
GMED earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts
↗
October 14, 2024
Via
Benzinga
NYSE:GMED is showing good growth, while it is not too expensive.
↗
October 02, 2024
In the world of growth stocks, NYSE:GMED shines as a value proposition.
Via
Chartmill
Looking Into Globus Medical's Recent Short Interest
↗
September 06, 2024
Via
Benzinga
Globus Medical Reports Third Quarter 2024 Results
November 05, 2024
From
Globus Medical
Via
GlobeNewswire
Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting
October 18, 2024
From
Globus Medical
Via
GlobeNewswire
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
October 15, 2024
From
Globus Medical
Via
GlobeNewswire
A Glimpse Into The Expert Outlook On Globus Medical Through 8 Analysts
↗
August 28, 2024
Via
Benzinga
Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions
October 02, 2024
From
Globus Medical
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 23, 2024
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm
September 20, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
While growth is established for NYSE:GMED, the stock's valuation remains reasonable.
↗
September 11, 2024
While growth is established for NYSE:GMED, the stock's valuation remains reasonable.
Via
Chartmill
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Domino’s and Encourages Investors to Contact the Firm
September 09, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Centuri, Medpace, Customers Bancorp, and Globus and Encourages Investors to Contact the Firm
August 30, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 26, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
GMED Investors Have Opportunity to Join Globus Medical, Inc. Securities Fraud Investigation with the Schall Law Firm
August 21, 2024
From
The Schall Law Firm
Via
Business Wire
Globus Medical Launches ADIRA™ XLIF™ Plate System
August 21, 2024
From
Globus Medical
Via
GlobeNewswire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
